Checking DFTX unusual options activity helps you spot when traders are making outsized bets on Definium Therapeutics Inc before the broader market catches on. Definium Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor DFTX unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching DFTX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking DFTX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and DFTX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Definium Therapeutics, Inc. is a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company’s lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Catalysts rarely arrive without a footprint, and DFTX unusual options activity is often where that footprint shows up first. Our scanner tracks Definium Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at DFTX unusual options volume on the call side or chasing put sweeps, Definium Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
